Shilian Liu

1.4k total citations
65 papers, 1.2k citations indexed

About

Shilian Liu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Shilian Liu has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 26 papers in Immunology and 9 papers in Oncology. Recurrent topics in Shilian Liu's work include Cell death mechanisms and regulation (21 papers), RNA Interference and Gene Delivery (11 papers) and Virus-based gene therapy research (9 papers). Shilian Liu is often cited by papers focused on Cell death mechanisms and regulation (21 papers), RNA Interference and Gene Delivery (11 papers) and Virus-based gene therapy research (9 papers). Shilian Liu collaborates with scholars based in China, Canada and Hong Kong. Shilian Liu's co-authors include Yanxin Liu, Dexian Zheng, Zhaoyu Qin, Juan Shi, Yaxi Zhang, Hong Ma, Minghong Jiang, Jinchun Zhang, Jing Gao and Dongsheng Wang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Shilian Liu

65 papers receiving 1.2k citations

Peers

Countries citing papers authored by Shilian Liu

Since Specialization

Citations

This map shows the geographic impact of Shilian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilian Liu more than expected).

Fields of papers citing papers by Shilian Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilian Liu. The network helps show where Shilian Liu may publish in the future.

Co-authorship network of co-authors of Shilian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shilian Liu. A scholar is included among the top collaborators of Shilian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilian Liu. Shilian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multifunctional all hydrogel-based smart dressing system fabricated by a self-healing cross-linking strategy for real-time monitoring of wound temperature, strain and on-demand drug delivery 2022 ·Journal of Materials Chemistry C ·(unknown), (unknown), Shilian Liu, (unknown), Yu Shi, Jian Geng, Jiajia Li, (unknown), Zhongze Gu, Hua Xu	24
2	Oxytocin signalling in dendritic cells regulates immune tolerance in the intestine and alleviates DSS-induced colitis 2021 ·Clinical Science ·Dandan Dou, (unknown), Xiangyu Zhai, Guosheng Li, Hongjuan Wang, Liying Han, (unknown), Yifei Ren, Shilian Liu, Chuanyong Liu, (unknown), Jingxin Li	21
3	Research progress on the effects of land consolidation on ecosystem services 2014 ·Zhongguo shengtai nongye xuebao ·Shilian Liu	2
4	RIP1 modulates death receptor mediated apoptosis and autophagy in macrophages 2014 ·Molecular Oncology ·Zhenyu Yao, Peng Zhang, Hui Guo, Juan Shi, Shilian Liu, Yanxin Liu, Xi‐Long Zheng	20
5	Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation 2014 ·Molecular Neurobiology ·Yanyan Zhu, Zhaoyu Qin, (unknown), Mingchong Yang, (unknown), Ting Shen, Shilian Liu	10
6	Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma 2011 ·BMC Cancer ·Minghong Jiang, Zheng Liu, Yang Xiang, Hong Ma, Shilian Liu, Yanxin Liu, Dexian Zheng	31
7	Adeno-associated virus-mediated anti-DR5 chimeric antibody expression suppresses human tumor growth in nude mice 2011 ·Cancer Letters ·(unknown), (unknown), Yaxi Zhang, Shilian Liu, Juan Shi, Yanxin Liu, Dexian Zheng	10
8	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces chemotactic migration of monocytes via a death receptor 4-mediated RhoGTPase pathway 2010 ·Molecular Immunology ·Wei Wei, Dongsheng Wang, Juan Shi, Yang Xiang, Yaxi Zhang, Shilian Liu, Yanxin Liu, Dexian Zheng	23
9	Targeting a Novel N-terminal Epitope of Death Receptor 5 Triggers Tumor Cell Death 2010 ·Journal of Biological Chemistry ·Peng Zhang, Yong Zheng, Juan Shi, Yaxi Zhang, Shilian Liu, Yanxin Liu, Dexian Zheng	7
10	Death receptor 5‐recruited raft components contributes to the sensitivity of Jurkat leukemia cell lines to TRAIL‐induced cell death 2009 ·IUBMB Life ·(unknown), Juan Shi, Yaxi Zhang, Shilian Liu, Yanxin Liu, Dexian Zheng	15
11	Knockdown of c‐FLIP_L enhanced AD5‐10 anti‐death receptor 5 monoclonal antibody‐induced apoptosis in human lung cancer cells 2009 ·Cancer Science ·Feng Chen, Juntang Guo, Yaxi Zhang, Yu Zhao, Naikang Zhou, Shilian Liu, Yanxin Liu, Dexian Zheng	8
12	Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐induced chemokine release in both TRAIL‐resistant and TRAIL‐sensitive cells via nuclear factor kappa B 2008 ·FEBS Journal ·Wanhu Tang, Weimin Wang, Yaxi Zhang, Shilian Liu, Yanxin Liu, Dexian Zheng	42
13	Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barré Syndrome by a proteomical approach 2008 ·Molecular Biology Reports ·(unknown), Shilian Liu, Zhaoyu Qin, Yazhou Cui, (unknown), (unknown)	21
14	Actinomycin D enhances TRAIL-induced caspase-dependent and -independent apoptosis in SH-SY5Y neuroblastoma cells 2007 ·Neuroscience Research ·Mingjie Wang, Shilian Liu, Yanxin Liu, Dexian Zheng	34
15	PKCδ protects human breast tumor MCF‐7 cells against tumor necrosis factor‐related apoptosis‐inducing ligand‐mediated apoptosis 2005 ·Journal of Cellular Biochemistry ·Jindan Zhang, Ning Liu, Jingchun Zhang, Shilian Liu, Yanxin Liu, Dexian Zheng	26
16	Oral adeno‐associated virus‐sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice† 2005 ·Hepatology ·Hong Ma, Yanxin Liu, Shilian Liu, Ruian Xu, Dexian Zheng	31
17	A Novel Anti-human DR5 Monoclonal Antibody with Tumoricidal Activity Induces Caspase-dependent and Caspase-independent Cell Death 2005 ·Journal of Biological Chemistry ·Yabin Guo, Caifeng Chen, Yong Zheng, Jinchun Zhang, Xiaohui Tao, Shilian Liu, Dexian Zheng, Yanxin Liu	69
18	Recombinant adeno‐associated virus‐mediated TRAIL gene therapy suppresses liver metastatic tumors 2005 ·International Journal of Cancer ·Hong Ma, Yanxin Liu, Shilian Liu, Hsiang‐Fu Kung, Xueying Sun, Dexian Zheng, Ruian Xu	34
19	5‐Fluorouracil enhances apoptosis sensitivity of T lymphocytes mediated by CD3ε 2004 ·Cell Biochemistry and Function ·Hong Cheng, Yanxin Liu, Shilian Liu, Dexian Zheng	1
20	Tyrosine Mutation in CD3ε–ITAM Blocked T Lymphocyte Apoptosis Mediated by CD3ε 2003 ·Immunological Investigations ·Yanxin Liu, Yiping He, Jin Zhang, Liqun Jiang, Shilian Liu, Dexian Zheng	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact